STOCK TITAN

Innovex International, Inc. 8-K Filings

INVX NYSE

Every 8-K that Innovex International, Inc. (INVX) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 8-K covers material events a company has to report between its quarterly reports, so if you follow INVX and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full INVX filings page.

Rhea-AI Summary

Innovex International, Inc. entered into an Underwriting Agreement on August 6, 2026 with affiliates of Amberjack Capital Partners, L.P. as selling stockholders and Barclays Capital Inc. as underwriter for an underwritten secondary offering of common stock.

The selling stockholders sold 5,000,000 shares of Innovex common stock, par value $0.01 per share, to the underwriter at a price of $28.71 per sharereceived no proceeds from the sale. The secondary offering was conducted under an effective shelf registration statement on Form S-3 (File No. 333-282178), including a base prospectus dated September 17, 2024 and prospectus supplements dated August 6 and August 10, 2026. The agreement includes customary representations, warranties, conditions, termination rights and indemnification of the underwriter by the company and the selling stockholders.

Rhea-AI Summary

Innovex International reported strong second-quarter 2026 results. Revenue was $245 million, up 2% sequentially and 9% year-over-year, with net income of $25 million and a 10% net margin. Adjusted EBITDA was $48 million with a 20% margin, and Free Cash Flow was $30 million.

The company generated $37 million of net cash from operating activities and about $7 million of capital expenditures, ending the quarter with $222 million of cash and cash equivalents and no bank debt. Income from operations for the twelve months ended June 30 2026 was $100 million, supporting a 12% Return on Capital Employed.

On July 1 2026, Innovex closed the acquisition of TCO Group AS in a cash-and-stock transaction valued at $95 million, described as high-margin and expected to be accretive to earnings per share. For third-quarter 2026, the company expects revenue of $260–$270 million and Adjusted EBITDA of $51–$57 million, including TCO contributions.

Rhea-AI Summary

Innovex International, Inc. filed an amended current report to update the disclosed share issuance related to a completed acquisition.

On July 1, 2026, Innovex closed its acquisition of TCO Group AS and issued 1,060,713 shares of common stock as merger consideration. The share count was based on the average of the volume weighted average trading prices on the New York Stock Exchange over the fifteen trading days immediately before June 15, 2026. The issuance relied on an exemption from registration under Section 4(a)(2) of the Securities Act of 1933.

Rhea-AI Summary

Innovex International, Inc. agreed to acquire all issued shares of Norwegian oilfield equipment company TCO Group AS for an aggregate Purchase Price of approximately $95 million, paid as $65 million in cash and $30 million in newly issued Innovex common shares.

The stock portion is priced at about $28.20 per share, resulting in roughly 1,063,829 consideration shares subject to a six‑month lock‑up after closing. TCO Group generated 2025 revenue of $70 million, net income of $12.4 million, Adjusted EBITDA of $17.6 million and Free Cash Flow of $11.5 million, implying an 18% net margin and 25% Adjusted EBITDA Margin.

Based on 2025 figures, Innovex estimates a Transaction Return on Capital Employed of 14% and expects the deal to be approximately 13% accretive to its basic EPS as if completed at the start of 2025. Closing is expected early in the third quarter of 2026, subject to customary conditions.

Rhea-AI Summary

Innovex International, Inc. reported the results of its annual stockholder meeting held on May 7, 2026. Stockholders elected three directors to three-year terms expiring at the 2029 annual meeting, with John Lovoi, Angie Sedita and Will Donnell each receiving over 55 million votes in favor.

Stockholders also ratified PricewaterhouseCoopers LLP as the independent registered public accounting firm for the year ending December 31, 2026, with 65,317,004 votes for and minimal opposition. An advisory vote on executive compensation was approved with 61,831,241 votes for, 586,796 against and 101,028 abstentions, indicating broad support for the current pay programs.

Rhea-AI Summary

Innovex International reported mixed first quarter 2026 results, combining strong cash generation with a headline legal charge. Revenue was $239 million, down 13% sequentially and 1% year-over-year, while the company recorded a net loss of $16.7 million and a net margin of (7)%.

Excluding one-time items, performance was stronger: Adjusted EBITDA was $49.3 million with a 21% margin, and Free Cash Flow was $14.0 million, supported by net cash from operations of $19.8 million and modest capital expenditures. Innovex ended the quarter with $200.7 million in cash and cash equivalents and no bank debt, highlighting a solid balance sheet.

Results were heavily impacted by a $48.8 million provision for legal settlement and related defense costs linked to ongoing litigation, which turned income from operations negative despite otherwise profitable operations. Strategically, Innovex closed the $16 million acquisition of Drilling Innovative Solutions, repurchased $14.1 million of its shares, substantially completed the exit of its Eldridge facility, and won two subsea projects in Asia, each valued above $20 million. For Q2 2026, management guides to revenue of $235–$245 million and Adjusted EBITDA of $43–$48 million, reflecting a slightly less favorable mix and potential disruption from conflict in the Middle East.

Rhea-AI Summary

Innovex International, Inc. disclosed that a jury in the U.S. District Court for the Southern District of Texas returned a verdict against its wholly owned subsidiary, Downhole Well Solutions, LLC, in a patent infringement case brought by Impulse Downhole Solutions entities. The jury found the remaining asserted patent claims valid, determined that DWS infringed them and characterized the infringement as willful, awarding Impulse approximately $47.6 million in damages. The damages amount may increase or decrease after further proceedings, and no judgment has been entered yet. Innovex strongly disagrees with the verdict, plans to pursue post-trial motions, and expects to appeal any judgment to the U.S. Court of Appeals for the Federal Circuit.

Rhea-AI Summary

Innovex International, Inc. supported a secondary share sale by major stockholders and simultaneously executed a share repurchase. Affiliates of Amberjack Capital Partners sold 5,750,000 shares of common stock at $25.75 per share, and underwriters exercised a 30-day option for an additional 862,500 shares. Innovex did not sell any shares or receive proceeds from this Offering. Instead, it repurchased 575,000 shares from the underwriters for about $14.1 million under its existing buyback program, leaving roughly $76.6 million available for future repurchases. A committee of independent directors approved the transaction, and both the Offering and repurchase closed on February 27, 2026.

Rhea-AI Summary

Innovex International, Inc. reported strong fourth-quarter and full-year 2025 results, highlighted by Q4 revenue of $273,602,000, up 14% sequentially. Q4 net income was $13,968,000 with a 5% net margin, and Adjusted EBITDA reached $52,108,000 with a 19% margin.

For full-year 2025, revenue grew to $978,251,000 and income from operations was $132,625,000. The company generated Q4 Free Cash Flow of $43,311,000 and $155,780,000 for the year, ending 2025 with $203,407,000 in cash and cash equivalents and no bank debt. Management guided Q1 2026 revenue to $225,000,000–$235,000,000 and Adjusted EBITDA to $38,000,000–$42,000,000, noting lower subsea deliveries and a plan to improve subsea margins after exiting the Eldridge facility by the end of Q2 2026.

Rhea-AI Summary

Innovex International (INVX) announced a Board change. Director Carri Lockhart, who chairs the Nominating and Governance Committee and also serves on the Audit Committee, informed the Board on November 5, 2025 that she will resign effective March 2, 2026.

The company stated her decision did not arise from any disagreement with Innovex on operations, policies, or practices. This is a governance update with a defined future effective date and no reported dispute.

Rhea-AI Summary

Innovex International (INVX) furnished an update via Form 8-K, announcing it issued a press release with results for the quarter ended September 30, 2025. The release, included as Exhibit 99.1, contains certain non-GAAP financial measures with reconciliations to the most comparable GAAP metrics.

The information under Items 2.02 and 7.01 is being furnished, not filed, and is not subject to Section 18 liabilities. The Company notes it discloses material information through SEC filings, press releases, public calls, and its investor site at investors.innovex-inc.com.